DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q2 2021 vs. Q1 2021
How the institutions holding DBV Technologies S.A. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 44 | 48 | +4 |
| Shares | 36.7M | 36.6M | −177.1K (−0.5%) |
| Value | $197.5M | $201.5M | +$4.04M (+2.0%) |
New holders (6)
Institutions that held DBV Technologies S.A. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 285,500 | $1.56M | 0.48% |
| Optiver Holding B.V. | 3,369 | $18.0K | 0.00% |
| Quadrant Capital Group LLC | 2,002 | $11.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,893 | $10.0K | 0.00% |
| State of Wyoming | 1,226 | $7.00K | 0.00% |
| Signaturefd, LLC | 92 | $1.00K | 0.00% |
Sold out (2)
Institutions that held DBV Technologies S.A. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 18,715 | $100.0K |
| Meridian Wealth Partners, LLC | 2,000 | $11.0K |